SimonMed Imaging partners with HeartLung to offer AI-based bone density screening nationwide: Scottsdale, Arizon Saturday, February 22, 2025, 18:00 Hrs [IST] SimonMed Imaging, one ...
Better cardiovascular health significantly reduced the risk for bone fractures related to osteoporosis, according to results from a cross-sectional study.The findings “underscore the importance of ...
Calcium and magnesium each offer health benefits, so does taking them together increase their impact on your health? Learn ...
Skeletal conditions such as developmental dysplasia of the hip (DDH), osteoporosis, and osteoarthritis affect millions ...
The FDA has approved the biologics license applications for Ospomyv and Xbryk, biosimilars to Prolia and Xgeva, respectively.
Interdisciplinary collaboration is key to reducing the risk for osteonecrosis of the jaw and improving patient care.
The Osteoporosis Society of the Philippines Foundation Inc. (OSPFI) estimates that by 2050, around 10.2 million Filipinos ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
The FDA and European Medicines Agency (EMA) granted approval, with interchangeability in the US, to Samsung Bioepis' ...
The FDA has approved two new biosimilars of denosumab-dssb to treat osteoporosis, increase bone mass, prevent ...
Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback